RT Journal Article
T1 Recommendations for antibiotic selection for severe nosocomial infections
A1 Mensa, Josep
A1 Barberan, Jose
A1 Ferrer, Ricard
A1 Borges, Marcio
A1 Rascado, Pedro
A1 Maseda, Emilio
A1 Oliver, Antonio
A1 Marco, Francesc
A1 Adalia, Ramon
A1 Aguilar, Gerardo
A1 Estella, Angel
A1 Leon Lopez, Rafael
A1 Robles Marcos, Manuel S.
A1 Gonzalez de Molina, Fco J.
A1 Serrano Garcia, Ricardo
A1 Salavert, Miguel
A1 Fernandez Gomez, Javier
A1 Poliakova, Yuliya
A1 Pasquau, Juan
A1 Ramon Azanza, Jose
A1 Bou Arevalo, German
A1 LLinares Mondejar, Pedro
A1 Cardinal-Fernandez, Pablo
A1 Soriano, Alex
K1 sepsis
K1 septic shock
K1 severe infection
K1 selection and optimization of antimicrobial treatment
K1 ceftazidime-avibactam
K1 ceftolozane-tazobactam
K1 meropenem
K1 C-reactive protein
K1 Blood-stream infections
K1 International consensus definitions
K1 Klebsiella-pneumoniae infection
K1 Community-acquired pneumonia
K1 Intensive-care units
K1 Acute kidney injury
K1 Septic shock
K1 Severe sepsis
K1 Antimicrobial therapy
AB Severe infection and its evolution to sepsis are becoming more prevalent every day and are among the leading causes of critical illness and mortality. Proper management is crucial to improve prognosis. This document addresses three essential points that have a significant impact on this objective: a) early recognition of patients with sepsis criteria, b) identification of those patients who suffer from an infection and have a high risk of progressing to sepsis, and c) adequate selection and optimization of the initial antimicrobial treatment.
PB Sociedad espanola quimioterapia
SN 0214-3429
YR 2021
FD 2021-10-01
LK https://hdl.handle.net/10668/25097
UL https://hdl.handle.net/10668/25097
LA en
DS RISalud
RD Apr 7, 2025